Cancer

Questions discussed in this category

How do you approach treatment of rheumatoid arthritis in a patient with an active hematologic malignancy (such as leukemia or lymphoma) after methotrexate failure?

Does your management change if there is renal involvement of the malignancy?

2 Answers available

How would you treat uveitis in a patient with a history of cutaneous T cell lymphoma?

Patient was previously well controlled on methotrexate, which was discontinued during cancer treatment.

1 Answer available

What is the biologic of choice in a patient with RA and history of non-melanoma skin cancer?

2 Answers available

Is it appropriate to consider biologic therapy for treatment of RA in a patient with non-small cell lung carcinoma treated with radiation therapy, who has ongoing active synovitis uncontrolled by conventional DMARDs?

1 Answer available

What is the safest approach to treating refractory RA in the setting of an active solid organ malignancy?

Prior therapies include MTX, abatacept, rituximab

1 Answer available

Papers discussed in this category

Arthritis Care Res (Hoboken), 2016 Jan

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Arthritis Rheumatol, 2016 Jan

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Related Topics